Cannabinoid Pain Relief Study
Part of Brain & nervous system clinical trials.
This trial tests whether a cannabinoid cream or gel can help with pain from joints, bones, or other non-muscle sources. It aims to see if it provides real pain relief for people who use it as directed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have pain mainly in your joints, bones, or other non-muscle areas (like from a fracture or arthritis).
- You do not have open sores, infections, or skin conditions at the place where you would apply the cream.
- You are not taking any substances that are banned by the World Anti-Doping Agency (WADA) that could interfere with the study.
- You are not an athlete in official competition during the study if you are using a THC-containing product.
- You have not had a severe muscle tear or broken bone in the last 30 days.
- You are able to use the study's follow-up platform (like an app or website).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests how a new cannabinoid product affects people with ongoing musculoskeletal pain (like arthritis or injuries). It’s meant to see whether the product can improve pain for eligible adults who are not already using CBD regularly.
This trial tests a full-spectrum cannabis extract (a product containing many cannabis compounds) to see if it helps with chronic pain and affects bone health in women. You will receive either the cannabis extract or a placebo (a dummy pill) in a random order, and neither you nor the study team will know which one you are taking at the time.
This study tests if cannabinoid medications can reduce pain interference in daily life for people with hip or knee osteoarthritis. It may be a new option for moderate to severe pain.
This Phase 2 study tests cannabis-derived products to see if they reduce neuropathic (nerve-related) pain in veterans. It may help people whose pain is persistent and causes significant daily impact, especially if certain exam tests show allodynia (pain from normally non-painful touch).
This study tests if a daily oral CBD product can safely reduce moderate to severe upper extremity pain (pain score over 5 out of 10) that has lasted at least 3 months. It compares CBD to a placebo to see if it helps with bone, joint, tendon, ligament, muscle, or fibromyalgia pain, including post-surgery pain in the arm or hand.
This Phase 2 study tests whether a cannabinoid-related treatment changes how pain works in people with knee osteoarthritis. It uses questionnaires, MRI, and gentle nerve testing to understand if treatment helps pain and pain-related signals.
Hear when a new Chronic Musculoskeletal Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.